Dose Escalation for Prostate Cancer Radiotherapy: Predictors of Long-Term Biochemical Tumor Control and Distant Metastases–Free Survival Outcomes-Reference-Cited by-同舟云学术

Dose Escalation for Prostate Cancer Radiotherapy: Predictors of Long-Term Biochemical Tumor Control and Distant Metastases–Free Survival Outcomes

Published:2011-12 Issue:6 Volume:60 Page:1133-1139
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Zelefsky Michael J.,Pei Xin,Chou Joanne F.,Schechter Michael,Kollmeier Marisa,Cox Brett,Yamada Yoshiya,Fidaleo Anthony,Sperling Dahlia,Happersett Laura,Zhang Zhigang

Publisher

Elsevier BV

Subject

Urology

Reference20 articles.

1. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial;Pollack;Int J Radiat Oncol Biol Phys,2002

2. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from Proton Radiation Oncology Group/American College of Radiology 95–09;Zietman;J Clin Oncol,2010

3. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68Gy of radiotherapy with 78Gy;Peeters;J Clin Oncol,2006

4. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial;Dearnaley;Lancet Oncol,2007

5. Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer: who dies of disease?;Kuban;Int J Radiat Oncol Biol Phys,2011

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Depth Of Hydrogel Spacer Rectal Wall Infiltration (RWI) Was Not Associated With Rectal Toxicity: Results From A Randomized Prospective Trial;Advances in Radiation Oncology;2024-09

2. Treatment outcome of localized prostate cancer using transperineal ultrasound image-guided radiotherapy;Radiation Oncology;2024-08-01

3. Significance of androgen‐deprivation therapy for intermediate‐ and high‐risk prostate cancer treated with high‐dose radiotherapy: A literature review;International Journal of Urology;2024-07-17

4. Histopathology-validated gross tumor volume delineations of intraprostatic lesions using PSMA-positron emission tomography/multiparametric magnetic resonance imaging;Physics and Imaging in Radiation Oncology;2024-07

5. Dosimetric evaluation of ultrafractionated dose escalation with simultaneous integrated boost to intraprostatic lesion using 1.5-Tesla MR-Linac in localized prostate cancer;Reports of Practical Oncology and Radiotherapy;2024-02-16